Literature DB >> 8441427

A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones.

G C Curhan1, W C Willett, E B Rimm, M J Stampfer.   

Abstract

BACKGROUND: A high dietary calcium intake is strongly suspected of increasing the risk of kidney stones. However, a high intake of calcium can reduce the urinary excretion of oxalate, which is thought to lower the risk. The concept that a higher dietary calcium intake increases the risk of kidney stones therefore requires examination.
METHODS: We conducted a prospective study of the relation between dietary calcium intake and the risk of symptomatic kidney stones in a cohort of 45,619 men, 40 to 75 years of age, who had no history of kidney stones. Dietary calcium was measured by means of a semiquantitative food-frequency questionnaire in 1986. During four years of follow-up, 505 cases of kidney stones were documented.
RESULTS: After adjustment for age, dietary calcium intake was inversely associated with the risk of kidney stones; the relative risk of kidney stones for men in the highest as compared with the lowest quintile group for calcium intake was 0.56 (95 percent confidence interval, 0.43 to 0.73; P for trend, < 0.001). This reduction in risk decreased only slightly (relative risk, 0.66; 95 percent confidence interval, 0.49 to 0.90) after further adjustment for other potential risk factors, including alcohol consumption and dietary intake of animal protein, potassium, and fluid. Intake of animal protein was directly associated with the risk of stone formation (relative risk for men with the highest intake as compared with those with the lowest, 1.33; 95 percent confidence interval, 1.00 to 1.77); potassium intake (relative risk, 0.49; 95 percent confidence interval, 0.35 to 0.68) and fluid intake (relative risk, 0.71; 95 percent confidence interval, 0.52 to 0.97) were inversely related to the risk of kidney stones.
CONCLUSIONS: A high dietary calcium intake decreases the risk of symptomatic kidney stones.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8441427     DOI: 10.1056/NEJM199303253281203

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  206 in total

1.  The influence of a low protein diet in idiopathic hypercalciuria.

Authors:  E N Liatsikos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  1999       Impact factor: 2.370

Review 2.  Fortnightly review: Beneficial effects of potassium.

Authors:  F J He; G A MacGregor
Journal:  BMJ       Date:  2001-09-01

Review 3.  Prospective therapeutic studies in nephrolithiasis.

Authors:  D K Ackermann
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

4.  Milk, dietary calcium, and bone fractures in women: a 12-year prospective study.

Authors:  D Feskanich; W C Willett; M J Stampfer; G A Colditz
Journal:  Am J Public Health       Date:  1997-06       Impact factor: 9.308

Review 5.  Current aspects of epidemiology and nutrition in urinary stone disease.

Authors:  A Hesse; R Siener
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 6.  Genes in idiopathic calcium oxalate stone disease.

Authors:  H O Goodman; R Brommage; D G Assimos; R P Holmes
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

7.  Why oral calcium supplements may reduce renal stone disease: report of a clinical pilot study.

Authors:  C P Williams; D F Child; P R Hudson; G K Davies; M G Davies; R John; P S Anandaram; A R De Bolla
Journal:  J Clin Pathol       Date:  2001-01       Impact factor: 3.411

8.  Kidney stone analysis techniques and the role of major and trace elements on their pathogenesis: a review.

Authors:  Vivek K Singh; Pradeep K Rai
Journal:  Biophys Rev       Date:  2014-07-31

Review 9.  Predictive medicine in non-malignant urological disorders.

Authors:  Mariangela Mancini; Antonio Cisternino; Ivan Matteo Tavolini; Fabrizio Dal Moro; Pierfrancesco Bassi
Journal:  World J Urol       Date:  2003-12-20       Impact factor: 4.226

Review 10.  The pathogenesis, treatment and prevention of osteoporosis in men.

Authors:  Leif Mosekilde; Peter Vestergaard; Lars Rejnmark
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.